Table I.
Characteristics of the patients in the NAC+OP+R and NAC+R groups.
| NAC+OP+R group | NAC+R group | P-value | |
|---|---|---|---|
| No. of cases | 33 | 20 | |
| Age | a0.023 | ||
| Mean±SD | 46.2±13.2 | 54.2±9.8 | |
| Range | 22–69 | 37–67 | |
| FIGO stage | b0.432 | ||
| IIIa | 1 | 0 | |
| IIIb | 32 | 20 | |
| Histology | b0.220 | ||
| SCC | 29 | 18 | |
| A | 4 | 1 | |
| AS | 0 | 0 | |
| Others | 0 | 1 |
a
Student’s t-test;
b
χ2 test; SCC, NAC+OP+R, neoadjuvant chemotherapy + surgery + radiotherapy; NAC+R, neoadjuvant chemotherapy + radiotherapy; FIGO, International Federation of Gynecology and Obstetrics; SCC, squamous cell carcinoma; A, adenocarcinoma; AS, adenosquamous carcinoma.